Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cell

[News]

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.

More... (https://www.news-medical.net/news/20240219/Novel-monoclonal-antibody-shows-promise-in-Targeting-HER2-positive-breast-cancer-cells.aspx)